Teleconsultation was launched as a feature rather than marketed as a patient decision with real uncertainty. To solve this, hospitals must address three gaps: define which visits video is actually suited for (triage, follow-ups, chronic reviews), build doctor trust deliberately through visible credentials and physician continuity, and clearly outline the practical mechanics of booking, payments, and prescriptions.
In teleconsultation adoption across Indian hospitals, patient willingness is not the bottleneck; rather, uncertainty about diagnosis reliability, format comfort, and lack of clear guidance leads patients to default to in-person OPD visits.
Most Indian hospitals built the video-call infrastructure during the pandemic. Very few built the content that tells a patient when to use it — which is why the booking numbers quietly went back to where they started.
A mid-sized hospital adds a “Video Consultation” button to its website in 2021, because every hospital is doing it and the government is pushing eSanjeevani hard. The booking flow works. The doctors are trained on the platform. Three years later, the button is still there. Almost nobody clicks it.
The hospital’s leadership reads this as an adoption problem — “our patients still prefer coming in person,” “people here don’t trust video consultations,” “maybe teleconsultation just isn’t for our market.” All three conclusions are plausible-sounding and, for most hospitals, wrong.
The real problem sits one layer up. Teleconsultation was launched as a feature — a capability added to the website, a line item in the services menu. It was never marketed as what it actually is: a decision a patient has to make, with real uncertainty on their end, that nobody at the hospital bothered to help them make.
What the data actually says
Start with the thing most hospital leaders get backwards: Indian patients are not broadly opposed to video consultations. A 2023 cross-sectional study of patients and clinicians at a tertiary institution in Jodhpur found that 69% of patients said they would take another teleconsultation, 82.1% rated the overall experience as good, and 98.5% agreed it had made healthcare more accessible during COVID-19. Willingness is not the bottleneck.
An EY–Indian Pharmaceutical Alliance study, published in 2020 but still the most-cited baseline for India’s telemedicine trajectory, found that 64% of surveyed consumers showed increased willingness to adopt teleconsultation after the pandemic began. The same study projected the teleconsultation segment growing from roughly $100 million to $700 million over five years — a 48% compound annual growth rate. More recent market sizing from IMARC puts India’s broader telemedicine market on a 20.5% CAGR through 2033. The macro trend is not in question.
But the same EY–IPA study found 54% of patients questioned the reliability of an online diagnosis, and 30% said they weren’t comfortable with the technology or the virtual format itself. That’s not a rejection of teleconsultation. That’s a large group of people who are willing in principle and uncertain in practice — exactly the population a piece of well-written decision content is supposed to serve, and exactly the population most hospital websites say nothing to.
Look also at what happened to India’s largest teleconsultation platform, eSanjeevani, which had delivered over 276 million consultations by November 2024. Its direct-to-patient (OPD) usage rose sharply through 2020–21, when teleconsultation was the only option — and then fell off as in-person care became available again. Demand for teleconsultation, at scale, has tracked necessity and active promotion far more than it has tracked any stable patient preference. Left to market itself, it doesn’t.
That is the pattern playing out inside individual hospitals too. The capability got built because 2021 forced it. The marketing got built for exactly as long as the emergency lasted. Once patients had a choice again, nothing on the hospital’s website gave them a reason to keep choosing it — so they didn’t.
The three things nobody is telling the patient
Strip away the booking button and the platform integration, and most hospital teleconsultation pages are missing the same three things.
First: which visits this is actually for.
A patient facing a symptom doesn’t know whether their situation is “a video call is fine” or “I need to be examined.” Hospitals rarely say. The Jodhpur study is instructive here in the other direction too — 87.3% of patients who had a teleconsultation were subsequently called in for an in-person OPD visit anyway. That is not a failure of the teleconsultation; it’s a reminder of what teleconsultation is actually good for in most hospital settings: triage, follow-up, medication review, chronic-disease check-ins, second opinions, pre-visit screening.
It is a poor fit for a new acute symptom, anything that needs a physical exam, vitals, or in-person diagnostics, or anything the patient or doctor is genuinely worried could be serious.
A hospital that writes this distinction down, specifically, for its own specialties and common complaints — not as a generic disclaimer, but as real guidance — removes the single biggest reason people default to “just go in person, to be safe.”
This has to be written responsibly. The goal is not a symptom checker and it is not a funnel that nudges every patient toward video because video is cheaper to deliver. Overselling teleconsultation past its legitimate use cases is not a marketing win; it’s a liability and, more importantly, it’s the kind of thing that erodes exactly the trust the hospital is trying to build. The honest version of this content will send a meaningful share of readers straight to “book an in-person appointment instead” — and that’s the version worth publishing, because it’s the version patients will actually believe the next time.
Second: how a patient is supposed to trust a doctor they will meet, for the first time, on a screen.
In-person trust accrues through small physical signals most hospitals don’t even think about — the waiting room, the handshake, the framed degrees, watching the doctor read a file. None of that exists on a video call. What replaces it has to be built deliberately: the same doctor across consultations rather than whoever is free, visible credentials and specific experience (not a decorative bio), a clear explanation of what the consultation will and won’t cover, and continuity — knowing that this doctor, not a stranger, is reviewing the follow-up.
The clinician side of the Jodhpur study flags why this matters: 73% of clinicians found clinical evaluation genuinely harder over video, and 55.7% reported miscommunication as a real problem. If the doctors delivering the care find it harder to build confidence through a screen, the hospital’s content has to work harder to compensate — not paper over it with stock photography of a smiling doctor and a laptop.
Third: the practical mechanics nobody writes down.
How does a patient actually book one. What do they need to have ready — previous prescriptions, test reports, a stable connection, a quiet room. How does payment work. How does the prescription reach them, and does it connect to pharmacy delivery. What happens if the call drops, or the doctor needs to see them in person after all.
The same Jodhpur study’s patient complaints were almost entirely about exactly this layer — unanswered follow-up calls, no clear next appointment date, medication dosages that weren’t communicated clearly. None of that is a technology failure. It’s a content and process-communication failure, and it is the single most fixable thing on this list, because it doesn’t require persuading anyone of anything — it just requires writing it down.
Why this matters more than the adoption framing admits
None of this is a case for pushing teleconsultation harder. It’s the opposite. A hospital that writes honest, specific decision content — this is right for a video visit, this genuinely isn’t, here’s what to expect, here’s exactly how to book it — will see fewer people click the button out of confusion, and more people click it with the right expectations.
That’s a better outcome than more clicks. A patient who tries a video consultation for something it wasn’t suited for, has a bad experience, and gets called in anyway isn’t a near-miss. They’re someone who now distrusts the whole channel, and may say so to the next five people who ask them about it.
The capability most hospitals already have is not the constraint. The willingness most patients already have is not the constraint. What’s missing is the unglamorous, specific, patient-facing content that turns a feature into something a person can actually decide to use — written with enough restraint to say, clearly, when the answer is no.
Sources
- Telemedicine market to reach US$5.5 billion by 2025 with teleconsultation & e-pharmacy making up 90%: EY-IPA study
- Is telemedicine a holy grail in healthcare policy: clinicians’ and patients’ perspectives from an Apex Institution in Western India
- eSanjeevani — scale, growth and usage patterns of India’s national telemedicine platform
- India Telemedicine Market to Grow at 20.50% During 2025-2033